ESC 365 - Doctor Hiromichi Wada

Speaker illustration

Doctor Hiromichi Wada

National Hospital Organization Kyoto Medical Center, Kyoto (Japan)

Member of:

Impact of diabetes on vascular endothelial growth factor D and cardiovascular mortality in patients with suspected or known coronary artery disease: the ANOX study

Event: ESC Congress 2024

Topic: Diabetes and the Heart

Session: Diabetes and heart disease

Galectin-3 and cancer mortality in patients with suspected or known coronary artery disease: the ANOX study

Event: ESC Congress 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Complexities in coronary artery disease

Impact of atrial fibrillation on soluble fms-like tyrosine kinase-1 and cardiovascular events in patients with suspected or known coronary artery disease: The EXCEED-J Study

Event: ESC Congress 2021 - The Digital Experience

Topic: Biomarkers

Session: Acute Coronary Syndromes ePosters

Impact of smoking status on the relationships of growth differentiation factor 15 with mortality and cardiovascular events in patients with suspected or known coronary artery disease: the ANOX study

Event: ESC Congress 2020

Topic: Tobacco

Session: Risk Factors and Prevention ePosters

Impact of glucose tolerance status on the relationship between vascular endothelial growth factor D and mortality in patients with suspected coronary artery disease: a subanalysis of the ANOX study

Event: ESC Congress 2020

Topic: Metabolic Syndrome, Insulin, Insulin Resistance

Session: Risk Factors and Prevention ePosters

Vascular endothelial growth factor-D and mortality in suspected or known coronary heart disease patients with chronic kidney disease: a subanalysis of the ANOX study

Event: ESC Congress 2019

Topic: Comorbidities

Session: Long term prognosis in coronary artery disease

Diagnostic utility of biomarkers to predict coronary artery disease in patients with and without chronic kidney disease: baseline data from the EXCEED-J study

Event: ESC Congress 2018

Topic: Noninvasive Diagnostic Methods

Session: Biomarkers in acute coronary syndromes

Impact of smoking history on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

Event: ESC Congress 2017

Topic: Tobacco

Session: Prevention - Tobacco

Impact of atrial fibrillation on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Biomarkers - Heart Failure

Impact of chronic kidney disease on biomarkers predicting severity of coronary artery disease in patients with suspected coronary heart disease: baseline data from the ANOX study

Event: ESC Congress 2017

Topic: Biomarkers

Session: Bio and imaging markers in high risk individuals

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources